Assessment of the Efficacy of In Vivo CFTR Protein Replacement Therapy in CF Mice-Reference-Cited by-同舟云学术

Assessment of the Efficacy of In Vivo CFTR Protein Replacement Therapy in CF Mice

Published:1998-03 Issue:4 Volume:9 Page:521-528
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Ramjeesingh Mohabir,Huan Ling-Jun,Wilschanski Michael,Durie Peter,Li Canhui,Gyomorey Katalin,Wang Yanchun,Kent Geraldine,Tanswell Keith A.,Cutz Ernest,Ackerley Cameron,Bear Christine E.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.1998.9.4-521

Reference23 articles.

1. Nucleoside triphosphates are required to open the CFTR chloride channel

2. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR)

3. Systematic Analysis of Repeated Gene Delivery into Animal Lungs with a Recombinant Adenovirus Vector

4. Anionic Phospholipids Activate ATP-sensitive Potassium Channels

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A liposomal platform for the delivery of ion channel proteins for treatment of channelopathies — Application in therapy of cystic fibrosis;International Journal of Biological Macromolecules;2023-12

2. A Systematic Review of the Effect of Cystic Fibrosis Treatments on the Nasal Potential Difference Test in Animals and Humans;Diagnostics;2023-09-29

3. Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases;Molecular Therapy;2019-04

4. Genetic Disease;Biotechnology;2008-03-20

5. Amiloride-insensitive nasal potential difference varies with the menstrual cycle in cystic fibrosis;Pediatric Pulmonology;2007